I Tried EVERY Controversial Focus Drug

Key wellness + productivity strategies mentioned

1) Use “legal focus” thoughtfully: Modafinil (Modafanyl)

• Treat it as a daytime focus tool, not a permanent baseline.

Pros (reported):

• Sharper attention and easier focus
• No “jitters” / less crash for him
• Feels “Limitless”-like / in-flow

Main cautions (reported):

• Half-life 10–15 hours → can interfere with sleep quality if taken too late or too frequently
• Consider lowest effective dose and avoid daily use if sleep is sensitive
• Off-label use risk: requires doctor prescription for qualifying conditions (healthy use is technically off-label)

2) Psychedelics: use-context only; not for “task focus”

• He frames psychedelics as potentially useful for insight/breakthroughs, not spreadsheet/work focus.

Mechanism (described):

• Loosens the “filter” so more information enters; brain regions communicate differently

Practical caution for productivity:

• Too long/too disruptive in the middle of the day for tasks (e.g., LSD 8–12 hours; DMT ~15 minutes but still impractical)

Microdosing conclusion:

• Evidence for improved focus is weak; any “sharpness” may be placebo (feelings may improve without performance change)

3) Ketamine + MDMA: therapeutic/emotional work, not performance focus

Ketamine (described as dissociative):

• Valuable for meditation/spiritual practice and emotional/therapeutic sessions
• Not consistent with “focus on the task” because it pulls you away from task engagement

MDMA (empathy/serotonin):

• Good for trauma/connection work
• Not good for focus afterward (he describes a “serotonin burn,” flat mood/irritability for days)

4) Understand tolerance: many “focus drugs” can become self-adjusting

• Core lesson: repeatedly using a substance changes receptors such that it stops feeling special; you then take more to feel normal.
• Cocaine is used as his example of rapid tolerance + receptor pullback.
• He claims most drugs listed share this “same signature” tolerance effect.

5) Prefer “designed-for-brain” tools: Racetams / “nootropics”

Racetam family is described as:

• Subtle effects that can stack over time
• Not primarily stimulant-like

Key caution (reported):

• May burn through choline, which is needed for acetylcholine
• He recommends balancing with eggs and/or acetylcholine support (with age-dependent caution: muscle cramps risk if you’re young and increase acetylcholine)

6) Consider lower-risk foundational habits first

He repeatedly emphasizes:

• Fix sleep first
• Morning sunlight
• Walks
• Do lifestyle “biohacking” before stacking drugs/supplements

7) The “king” he crowns: Nicotine (pharmaceutical nicotine, not smoking/vaping)

He argues nicotine can improve:

• Alertness
• Attention
• Working memory
• Fine motor speed

Claim:

• Benefits are seen even in non-smokers (not just withdrawal relief)

Half-life:

• ~2 hours → can take it mid-afternoon and still fall asleep

Important harm-control rules (his “four rules”):

• Never smoke or vape it
• Don’t use it “once/socially”; avoid “trying random vape flavors”
• Use smallest dose (suggests ~1–3 mg; warns starting around 6 mg can cause dizziness/nausea)
• Don’t take daily: recommend spacing (e.g., a day off each week, using it only for the session that “matters”)

Who should avoid nicotine (his cautions):

• Heart/blood pressure issues (ask a real doctor)
• People who vomit with nicotine (possible genetic metabolism sensitivity)
• Pregnancy: avoid
• Under ~25: be cautious due to brain development

Clarification on harm attribution:

• Cancer risk comes from smoke/tar/combustion byproducts, not nicotine itself.

8) Don’t skip basics: he explicitly mentions Creatine

• He frames creatine as a strong foundational cognitive/mitochondrial enhancer (“Danger creatine” is promoted).

---

Presenters / sources

• Presenter: Dave Asprey
• Source(s) referenced:
  • “Largest placebo-controlled microdosing study” (no authors named)
  • “2010 nicotine cognition meta-review” (41 double-blind, placebo-controlled studies; source not named beyond year/description)
  • WADA (World Anti-Doping Agency) and IOC (Olympics) regarding bans (organizations only; no specific reports cited by title)